BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen L, Guan H, Gu C, Cao Y, Shao J, Wang F. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Tumor Biol 2016;37:2497-507. [DOI: 10.1007/s13277-015-4071-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Azarbarzin S, Feizi MA, Safaralizadeh R, Kazemzadeh M, Fateh A. The Value of MiR-383, an Intronic MiRNA, as a Diagnostic and Prognostic Biomarker in Intestinal-Type Gastric Cancer. Biochem Genet. 2017;55:244-252. [PMID: 28243881 DOI: 10.1007/s10528-017-9793-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
2 Wang N, Wang Q, Shen D, Sun X, Cao X, Wu D. Downregulation of microRNA-122 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by activating epithelial-mesenchymal transition. Onco Targets Ther. 2016;9:2035-2047. [PMID: 27103830 DOI: 10.2147/ott.s92378] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
3 Hu B, Gong Z, Bi Z. Inhibition of miR-383 suppresses oxidative stress and improves endothelial function by increasing sirtuin 1. Braz J Med Biol Res 2020;53:e8616. [PMID: 31994599 DOI: 10.1590/1414-431X20198616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zeng B, Chen T, Luo J, Xie M, Wei L, Xi Q, Sun J, Zhang Y. Exploration of Long Non-coding RNAs and Circular RNAs in Porcine Milk Exosomes. Front Genet 2020;11:652. [PMID: 32714373 DOI: 10.3389/fgene.2020.00652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
5 Wu A, Li Y, Kong M, Zhu B, Liu R, Bao F, Ju S, Chen L, Wang F. Upregulated hsa_circ_0005785 Facilitates Cell Growth and Metastasis of Hepatocellular Carcinoma Through the miR-578/APRIL Axis. Front Oncol 2020;10:1388. [PMID: 32974140 DOI: 10.3389/fonc.2020.01388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang J, Zhou Y, Fei X, Chen X, Chen Y. Biostatistics mining associated method identifies AKR1B10 enhancing hepatocellular carcinoma cell growth and degenerated by miR-383-5p. Sci Rep 2018;8:11094. [PMID: 30038373 DOI: 10.1038/s41598-018-29271-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
7 Li Y, Zang H, Zhang X, Huang G. circ_0136666 Facilitates the Progression of Colorectal Cancer via miR-383/CREB1 Axis. Cancer Manag Res 2020;12:6795-806. [PMID: 32821160 DOI: 10.2147/CMAR.S251952] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
8 Zhao S, Gao X, Zang S, Li Y, Feng X, Yuan X. MicroRNA-383-5p acts as a prognostic marker and inhibitor of cell proliferation in lung adenocarcinoma by cancerous inhibitor of protein phosphatase 2A. Oncol Lett 2017;14:3573-9. [PMID: 28927114 DOI: 10.3892/ol.2017.6603] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
9 Lu H, Lei X, Zhang Q. Liver-specific knockout of histone methyltransferase G9a impairs liver maturation and dysregulates inflammatory, cytoprotective, and drug-processing genes. Xenobiotica 2019;49:740-52. [PMID: 29912608 DOI: 10.1080/00498254.2018.1490044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 Ma R, Gao P, Yang H, Hu J, Xiao JJ, Shi M, Zhao LN. Inhibition of cell proliferation and radioresistance by miR-383-5p through targeting RNA binding protein motif (RBM3) in nasopharyngeal carcinoma. Ann Transl Med 2021;9:123. [PMID: 33569425 DOI: 10.21037/atm-20-6881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Shang Y, Zang A, Li J, Jia Y, Li X, Zhang L, Huo R, Yang J, Feng J, Ge K, Yang Y, Zhang Y, Jiang J. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner. Biomedicine & Pharmacotherapy 2016;83:1175-81. [DOI: 10.1016/j.biopha.2016.08.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
12 Zhang Y, Wei C, Guo CC, Bi RX, Xie J, Guan DH, Yang CH, Jiang YH. Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis. Oncotarget 2017;8:107237-57. [PMID: 29291025 DOI: 10.18632/oncotarget.20883] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
13 Fang Z, He L, Jia H, Huang Q, Chen D, Zhang Z. The miR-383-LDHA axis regulates cell proliferation, invasion and glycolysis in hepatocellular cancer. Iran J Basic Med Sci 2017;20:187-92. [PMID: 28293396 DOI: 10.22038/ijbms.2017.8246] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
14 Guo Y, Luo W, Huang S, Zhao W, Chen H, Ma Y, Ye M, Nie Y, Zhang Y, Huang C, Zhou Q, He X, Chen M. DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:871-85. [PMID: 34377684 DOI: 10.2147/JHC.S312604] [Reference Citation Analysis]
15 Wan P, Chi X, Du Q, Luo J, Cui X, Dong K, Bing Y, Heres C, Geller DA. miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1. J Cell Biochem. 2018;119:9720-9729. [PMID: 30145803 DOI: 10.1002/jcb.27286] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
16 Ma H, Liu B, Wang S, Liu J. MicroRNA-383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain-containing protein 1: MicroRNA-383 is a tumor suppressor in human lung cancer. Cell Biochem Funct 2016;34:613-9. [DOI: 10.1002/cbf.3237] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
17 Wang J, Lu L, Luo Z, Li W, Lu Y, Tang Q, Pu J. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway. Biomedicine & Pharmacotherapy 2019;120:109551. [DOI: 10.1016/j.biopha.2019.109551] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
18 Ahmed N, Ahmed N, Pezacki JP. miR-383 Regulates Hepatic Lipid Homeostasis and Response to Dengue Virus Infection. ACS Infect Dis 2022. [PMID: 35254825 DOI: 10.1021/acsinfecdis.1c00470] [Reference Citation Analysis]
19 Cui Y, Chen LG, Yao HB, Zhang J, Ding KF. Upregulation of microRNA-383 inhibits the proliferation, migration and invasion of colon cancer cells. Oncol Lett 2018;15:1184-90. [PMID: 29399173 DOI: 10.3892/ol.2017.7409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
20 Han B, Lian L, Li X, Zhao C, Qu L, Liu C, Song J, Yang N. Chicken gga-miR-130a targets HOXA3 and MDFIC and inhibits Marek's disease lymphoma cell proliferation and migration. Mol Biol Rep 2016;43:667-76. [PMID: 27178573 DOI: 10.1007/s11033-016-4002-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
21 Xu Z, Zeng X, Li M, Liao J, Chen Q. MicroRNA-383 promotes reactive oxygen species-induced autophagy via downregulating peroxiredoxin 3 in human glioma U87 cells. Exp Ther Med 2021;21:439. [PMID: 33747176 DOI: 10.3892/etm.2021.9870] [Reference Citation Analysis]
22 Zhao L, Wang P, Liu Y, Cai H, Ma J, Liu L, Xi Z, Li Z, Liu X, Xue Y. MiR-383 inhibits proliferation, migration and angiogenesis of glioma-exposed endothelial cells in vitro via VEGF-mediated FAK and Src signaling pathways. Cellular Signalling 2017;30:142-53. [DOI: 10.1016/j.cellsig.2016.09.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
23 Bahreini F, Jabbari P, Gossing W, Aziziyan F, Frohme M, Rezaei N. The role of noncoding RNAs in pituitary adenoma. Epigenomics 2021;13:1421-37. [PMID: 34558980 DOI: 10.2217/epi-2021-0165] [Reference Citation Analysis]
24 Nowacka KH, Jabłońska E. Role of the APRIL molecule in solid tumors. Cytokine Growth Factor Rev 2021;61:38-44. [PMID: 34446365 DOI: 10.1016/j.cytogfr.2021.08.001] [Reference Citation Analysis]
25 Wang H, Xu Y, Jin M, Li H, Li S. miR-383 reduces keratinocyte proliferation and induces the apoptosis in psoriasis via disruption of LCN2-dependent JAK/STAT pathway activation. Int Immunopharmacol 2021;96:107587. [PMID: 33819732 DOI: 10.1016/j.intimp.2021.107587] [Reference Citation Analysis]
26 Karihtala P, Porvari K, Soini Y, Haapasaari KM. Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas. Oxid Med Cell Longev 2017;2017:2696071. [PMID: 28377796 DOI: 10.1155/2017/2696071] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
27 Chen E, Xu X, Liu R, Liu T. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression. Biomed Res Int 2018;2018:6784607. [PMID: 29951542 DOI: 10.1155/2018/6784607] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
28 Tu C, Chen W, Wang S, Tan W, Guo J, Shao C, Wang W. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2. J Cell Mol Med 2019;23:7190-9. [PMID: 30801960 DOI: 10.1111/jcmm.14197] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
29 Li P, Li Y, Ma L. Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR-383-5p/vesicle-associated membrane protein-2 axis. Pharmacol Res Perspect 2021;9:e00815. [PMID: 34223709 DOI: 10.1002/prp2.815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Cheng Y, Liu N, Yang C, Jiang J, Zhao J, Zhao G, Chen F, Zhao H, Li Y. MicroRNA-383 inhibits proliferation, migration, and invasion in hepatocellular carcinoma cells by targeting PHF8. Mol Genet Genomic Med 2020;8:e1272. [PMID: 32441881 DOI: 10.1002/mgg3.1272] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Detassis S, Grasso M, Del Vescovo V, Denti MA. microRNAs Make the Call in Cancer Personalized Medicine. Front Cell Dev Biol 2017;5:86. [PMID: 29018797 DOI: 10.3389/fcell.2017.00086] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 8.4] [Reference Citation Analysis]
32 Li X, Jin H, Lv Y, Liu C, Luo X, Liu J, Zhang Q, Yu Y, Zhao Z. Analysis of microRNA expression profiles during the differentiation of chicken embryonic stem cells into male germ cells. Anim Biotechnol 2022;:1-12. [PMID: 35020556 DOI: 10.1080/10495398.2021.2013858] [Reference Citation Analysis]
33 Yi Q, Xie W, Sun W, Sun W, Liao Y. A Concise Review of MicroRNA-383: Exploring the Insights of Its Function in Tumorigenesis. J Cancer 2022;13:313-24. [PMID: 34976192 DOI: 10.7150/jca.64846] [Reference Citation Analysis]
34 Teng P, Jiao Y, Hao M, Tang X. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2. J Cell Biochem 2018;119:5243-52. [PMID: 29236322 DOI: 10.1002/jcb.26585] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]